Macrogenics Inc (NASDAQ: MGNX) on Friday, plunged -7.83% from the previous trading day, before settling in for the closing price of $1.15. Within the past 52 weeks, MGNX’s price has moved between $1.10 and $19.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 45.47% annually for the last half of the decade. The company achieved an average annual earnings per share of -140.19%. With a float of $58.00 million, this company’s outstanding shares have now reached $62.82 million.
In an organization with 341 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 89.25%, operating margin of -74.54%, and the pretax margin is -44.51%.
Macrogenics Inc (MGNX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Macrogenics Inc is 8.07%, while institutional ownership is 84.02%. The most recent insider transaction that took place on Feb 15 ’25, was worth 1,083. In this transaction VP, Controller & Treasurer of this company sold 423 shares at a rate of $2.56, taking the stock ownership to the 9,532 shares.
Macrogenics Inc (MGNX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -140.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -28.62% during the next five years compared to 19.47% growth over the previous five years of trading.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Macrogenics Inc (MGNX) is currently performing well based on its current performance indicators. A quick ratio of 3.92 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.07, a number that is poised to hit -0.73 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.98 million. That was better than the volume of 0.7 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 4.10%. Additionally, its Average True Range was 0.16.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 0.57%, which indicates a significant decrease from 1.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.01% in the past 14 days, which was higher than the 67.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.3304, while its 200-day Moving Average is $3.3753. However, in the short run, Macrogenics Inc’s stock first resistance to watch stands at $1.1133. Second resistance stands at $1.1667. The third major resistance level sits at $1.2033. If the price goes on to break the first support level at $1.0233, it is likely to go to the next support level at $0.9867. The third support level lies at $0.9333 if the price breaches the second support level.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
Market capitalization of the company is 66.88 million based on 63,090K outstanding shares. Right now, sales total 149,960 K and income totals -66,970 K. The company made 19,350 K in profit during its latest quarter, and -15,420 K in sales during its previous quarter.
